AAAAAA
Results:
1-9
|
Results: 9
Authors:
Poynard, T
Ratziu, V
Charlotte, F
Goodman, Z
McHutchison, J
Albrecht, J
Citation: T. Poynard et al., Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, J HEPATOL, 34(5), 2001, pp. 730-739
Authors:
Ong, JP
Younossi, ZM
Gramlich, T
Goodman, Z
Mayes, J
Sarbah, S
Yen-Lieberman, B
Citation: Jp. Ong et al., Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C, TRANSPLANT, 71(10), 2001, pp. 1486-1488
Authors:
Slimane, SB
Albrecht, JK
Fang, JWS
Goodman, Z
Mizokami, M
Qian, K
Lau, JYN
Citation: Sb. Slimane et al., Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: amulticentre study based on 671 patients, J VIRAL HEP, 7(1), 2000, pp. 51-55
Authors:
Poynard, T
McHutchison, J
Davis, GL
Esteban-Mur, R
Goodman, Z
Bedossa, P
Albrecht, J
Citation: T. Poynard et al., Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C, HEPATOLOGY, 32(5), 2000, pp. 1131-1137
Authors:
Poynard, T
McHutchison, J
Goodman, Z
Ling, MH
Albrecht, J
Citation: T. Poynard et al., A la carte interferon for hepatitis C? Reply, HEPATOLOGY, 32(3), 2000, pp. 679-679
Authors:
Poynard, T
McHutchison, J
Goodman, Z
Ling, MH
Albrecht, J
Citation: T. Poynard et al., Clinical utility of early viral load quantification - Reply, HEPATOLOGY, 32(1), 2000, pp. 158-158
Authors:
Poynard, T
McHutchison, J
Goodman, Z
Ling, MH
Albrecht, J
Citation: T. Poynard et al., Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?, HEPATOLOGY, 31(1), 2000, pp. 211-218
Authors:
Mizokami, M
Albrecht, JK
Kato, T
Orito, E
Lai, VCH
Goodman, Z
Hong, Z
Lau, JYN
Citation: M. Mizokami et al., TT virus infection in patients with chronic hepatitis C virus infection - effect of primers, prevalence, and clinical significance, J HEPATOL, 32(2), 2000, pp. 339-343
Authors:
Dienstag, JL
Schiff, ER
Wright, TL
Perrillo, RP
Hann, HWL
Goodman, Z
Crowther, L
Condreay, LD
Woessner, M
Rubin, M
Brown, NA
Citation: Jl. Dienstag et al., Lamivudine as initial treatment for chronic hepatitis B in the United States, N ENG J MED, 341(17), 1999, pp. 1256-1263
Risultati:
1-9
|